INTERNATIONAL PATENT: DOMPE' FARMACEUTICI S.P.A., CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (F.S.P) FILES APPLICATION FOR "CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF TUMORS WITH LOW STROMAL CAV1 LEVELS"

GENEVA, June 10 -- DOMPE' FARMACEUTICI S.P.A. (Via Santa Lucia, 620122 Milano), CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III (F.S.P) (Melchor Fernandez Almagro, 328029 Madrid) filed a patent application (PCT/EP2024/083939) for "CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF TUMORS WITH LOW STROMAL CAV1 LEVELS" on Nov 28, 2024. With publication no. WO/2025/114450, the details related to the patent application was published on Jun 05, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BRANDOLINI, Laura (c/o Dompe farmaceutici SpaVia Campo di Pile, snc67100 L'Aquila), GIORGIO, Cris...